BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Wang C, Goel A. Role of gut microbiota in epigenetic regulation of colorectal Cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188490. [PMID: 33321173 DOI: 10.1016/j.bbcan.2020.188490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao Y, Kan H, Wang X, Zhi Y. Gut microbiome alterations in hereditary angioedema. Ann Allergy Asthma Immunol 2022;128:451-458.e6. [PMID: 35093554 DOI: 10.1016/j.anai.2022.01.021] [Reference Citation Analysis]
2 Koulouris A, Tsagkaris C, Messaritakis I, Gouvas N, Sfakianaki M, Trypaki M, Spyrou V, Christodoulakis M, Athanasakis E, Xynos E, Tzardi M, Mavroudis D, Souglakos J. Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies. Cancers (Basel) 2021;13:3522. [PMID: 34298740 DOI: 10.3390/cancers13143522] [Reference Citation Analysis]
3 Gao S, Khan MI, Kalsoom F, Liu Z, Chen Y, Chen Z. Role of gene regulation and inter species interaction as a key factor in gut microbiota adaptation. Arch Microbiol 2022;204:342. [PMID: 35595857 DOI: 10.1007/s00203-022-02935-5] [Reference Citation Analysis]
4 Xu Y, Yu X, Zhang M, Zheng Q, Sun Z, He Y, Guo W. Promising Advances in LINC01116 Related to Cancer. Front Cell Dev Biol 2021;9:736927. [PMID: 34722518 DOI: 10.3389/fcell.2021.736927] [Reference Citation Analysis]
5 Goel A. The era of biomarkers and precision medicine in colorectal cancer: an interview with Ajay Goel. Epigenomics 2022. [PMID: 35081730 DOI: 10.2217/epi-2022-0010] [Reference Citation Analysis]
6 Keenan JI, Frizelle FA. Biomarkers to Detect Early-Stage Colorectal Cancer. Biomedicines 2022;10:255. [PMID: 35203465 DOI: 10.3390/biomedicines10020255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]